Cargando…
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
Autores principales: | Gupta, Aastha, Juneja, Sandeep, Sahu, Suvanand, Yassin, Mohammed, Brigden, Grania, Wandwalo, Eliud, Rane, Saurabh, Mirzayev, Fuad, Zignol, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021682/ https://www.ncbi.nlm.nih.gov/pubmed/36962626 http://dx.doi.org/10.1371/journal.pgph.0001287 |
Ejemplares similares
-
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
por: Masini, Tiziana, et al.
Publicado: (2022) -
Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
por: Brigden, Grania, et al.
Publicado: (2019) -
Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP)
por: Juneja, Sandeep, et al.
Publicado: (2017) -
Opinion: To save whales, look to the sky
por: Sèbe, Maxime, et al.
Publicado: (2021) -
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
por: Brigden, Grania, et al.
Publicado: (2015)